AAV-mediated gene therapy in a GLDC-deficient mouse model of Non-Ketotic Hyperglycinemia (2023)
Attributed to:
The Glycine Cleavage System in Brain Development, Function and Disease
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1101/2023.12.15.571844
Publication URI: http://dx.doi.org/10.1101/2023.12.15.571844
Type: Preprint